R. William Hipkin
About R. William Hipkin
R. William Hipkin is a Senior Clinical Research Scientist at Bristol Myers Squibb with extensive experience in drug development and experimental medicine.
Current Role at Bristol Myers Squibb
R. William Hipkin serves as a Senior Clinical Research Scientist at Bristol Myers Squibb in Princeton, New Jersey. In this role, he supports global, registrational trials in late-stage colorectal cancer, contributing to advanced clinical research and development in the field of oncology. His position at Bristol Myers Squibb leverages his extensive background in experimental medicine, drug discovery, and development.
Previous Roles and Experience
R. William Hipkin has held various significant positions across multiple companies. He worked at Genesis Biotechnology Group as Director of Drug Development in Hamilton, NJ. He served as the Chief Scientific Officer at Transform Therapeutics. Additionally, he was a Senior Director and Clinical Study Manager at Onconova, and a Director of In Vitro Pharmacology at Adolor. His career also includes a long tenure at Schering-Plough, where he held multiple positions, including Senior Principal Scientist, Principal Scientist, and Associate Principal Scientist.
Academic Background and Education
R. William Hipkin holds a Ph.D. in Physiology & Biophysics from Dalhousie University, which he completed from 1986 to 1991. He also earned a M.S. in Reproductive Biology and a B.S. in Animal Science from the University of Guelph, completed in 1986 and 1983, respectively. His rigorous academic background has played a crucial role in shaping his expertise in various specialized fields of clinical research and drug development.
Teaching Experience
In addition to his professional work in the pharmaceutical industry, R. William Hipkin has served as an Adjunct Professor at Kean University and Union County College. He taught courses in New Jersey from 2018 to 2020, sharing his extensive knowledge and practical experience in drug discovery, pharmacology, and experimental medicine with students.
Specialized Expertise
R. William Hipkin specializes in drug discovery and development, with substantial expertise in various therapeutic areas. His areas of specialization include Immuno-Oncology, Oncology, Autoimmunity/Inflammation, and Neuroscience. He is knowledgeable in pharmacology, drug transporters, drug-drug interactions (DDI), and ADME (Absorption, Distribution, Metabolism, and Excretion). He also focuses on experimental medicine, particularly biomarkers and target engagement, integral to the progression of novel therapeutics.